SVB Leerink Downgrades Applied Molecular to Market Perform, Lowers Price Target to $2

SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.

SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.

Total
0
Shares
Related Posts